Loading clinical trials...
Loading clinical trials...
The Combined Effect of Botulinum Toxin Type A and Mirror Therapy in the Management of Chronic-Phase Upper Extremity Spasticity After Ischemic Stroke: A Double-Blind, Controlled Study
Conditions
Interventions
Botulinum toxin type A (Botox®, Allergan)
Mirror Therapy
+1 more
Locations
1
Turkey (Türkiye)
Liv hospital Vadistanbul
Istanbul, Istanbul, Turkey (Türkiye)
Start Date
May 15, 2024
Primary Completion Date
February 15, 2025
Completion Date
May 15, 2025
Last Updated
January 12, 2026
NCT07541560
NCT07367100
NCT07392450
NCT07185022
NCT07318714
NCT06596369
Lead Sponsor
Fatih Sultan Mehmet Training and Research Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions